Common developmental genome deprogramming in schizophrenia — Role of Integrative Nuclear FGFR1 Signaling (INFS)

Schizophrenia Research

Volumn 185, Issue , 2017, Pages 17-32

  Narla, S T ^a   Lee, Y W ^a   Benson, C A ^a   Sarder, P ^a   Brennand, K J ^b   Stachowiak, E K ^a   Stachowiak, M K ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Developmental hypothesis; Fibroblast Growth Factor Receptor 1; Genome regulation; miRNA; Schizophrenia

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; MICRORNA; RNA; TRANSCRIPTOME; FGFR1 PROTEIN, HUMAN; NOTCH1 PROTEIN, MOUSE; NOTCH1 RECEPTOR;

ADULT; ARTICLE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE INTERACTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; MALE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RNA SEQUENCE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UPREGULATION; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; GENOME; GENOMICS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GENOME; GENOMICS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICRORNAS; MODELS, BIOLOGICAL; MUTATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, NOTCH1; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANSCRIPTOME; YOUNG ADULT;

EID: 85009820774     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2016.12.012     Document Type: Article

References (100)

1. Akbarian, S., Bunney, W.E. Jr., Potkin, S.G., Wigal, S.B., Hagman, J.O., Sandman, C.A., Jones, E.G., Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50:3 (1993), 169–177.
2. Arnold, S.E., Ruscheinsky, D.D., Han, L.Y., Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol. Psychiatry 42:8 (1997), 639–647.
3. Baron, O., Foerthmann, B., Lee, Y.W., Terranova, C., Ratzka, A., Stachowiak, E.K., Grothe, C., Claus, P., Stachowiak, M.K., Cooperation of nuclear FGFR1 and Nurr1 offers a new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons. J. Biol. Chem., 2012.
4. Baron, O., Forthmann, B., Lee, Y.W., Terranova, C., Ratzka, A., Stachowiak, E.K., Grothe, C., Claus, P., Stachowiak, M.K., Cooperation of nuclear fibroblast growth factor receptor 1 and nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons. J. Biol. Chem. 287:24 (2012), 19827–19840.
5. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136:2 (2009), 215–233.
6. Benes, F.M., Kwok, E.W., Vincent, S.L., Todtenkopf, M.S., A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry 44:2 (1998), 88–97.
7. Berretta, S., Extracellular matrix abnormalities in schizophrenia. Neuropharmacology 62:3 (2012), 1584–1597.
8. Blanchard, J.J., Kring, A.M., Horan, W.P., Gur, R., Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr. Bull. 37:2 (2011), 291–299.
9. Bobbs, A.S., Saarela, A.V., Yatskievych, T.A., Antin, P.B., Fibroblast growth factor (FGF) signaling during gastrulation negatively modulates the abundance of microRNAs that regulate proteins required for cell migration and embryo patterning. J. Biol. Chem. 287:46 (2012), 38505–38514.
10. Bogerts, B., Hantsch, J., Herzer, M., A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol. Psychiatry 18:9 (1983), 951–969.
11. Brennand, K.J., Gage, F.H., Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. Stem Cells 29:12 (2011), 1915–1922.
12. Brennand, K.J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., McCarthy, S., Sebat, J., Gage, F.H., Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:7346 (2011), 221–225.
13. Brennand, K.J., Landek-Salgado, M.A., Sawa, A., Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. Biol. Psychiatry 75:12 (2014), 936–944.
14. Brennand, K.J., Silvas, J., Kim, Y., Tran, N., Simone, A., Ladran, I., Beaumont, K., Kim, H.-J., Mrksich, M., Fang, G., Zhang, B., Yates, J.R. 3rd, Gage, F.H., Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry, 2014.
15. Brennand, K., Savas, J.N., Kim, Y., Tran, N., Simone, A., Hashimoto-Torii, K., Beaumont, K.G., Kim, H.J., Topol, A., Ladran, I., Abdelrahim, M., Matikainen-Ankney, B., Chao, S.H., Mrksich, M., Rakic, P., Fang, G., Zhang, B., Yates, J.R. III, Gage, F.H., Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 20:3 (2015), 361–368.
16. Bryant, D.M., Stow, J.L., Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor. Traffic 6:10 (2005), 947–954.
17. Cannon, T.D., Keller, M.C., Endophenotypes in the genetic analyses of mental disorders. Annu. Rev. Clin. Psychol. 2 (2006), 267–290.
18. Chiang, C.H., Su, Y., Wen, Z., Yoritomo, N., Ross, C.A., Margolis, R.L., Song, H., Ming, G.L., Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 16:4 (2011), 358–360.
19. Chioni, A.M., Grose, R., FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior. J. Cell Biol. 197:6 (2012), 801–817.
20. Ciabrelli, F., Cavalli, G., Chromatin-driven behavior of topologically associating domains. J. Mol. Biol. 427:3 (2015), 608–625.
21. Ciruna, B., Rossant, J., FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell 1:1 (2001), 37–49.
22. Ciruna, B.G., Schwartz, L., Harpal, K., Yamaguchi, T.P., Rossant, J., Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development 124:14 (1997), 2829–2841.
23. Clarke, W.E., Berry, M., Smith, C., Kent, A., Logan, A., Coordination of fibroblast growth factor receptor 1 (FGFR1) and fibroblast growth factor-2 (FGF-2) trafficking to nuclei of reactive astrocytes around cerebral lesions in adult rats. Mol. Cell. Neurosci. 17:1 (2001), 17–30.
24. Coleman, S.J., Chioni, A.M., Ghallab, M., Anderson, R.K., Lemoine, N.R., Kocher, H.M., Grose, R.P., Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion. EMBO Mol. Med. 6:4 (2014), 467–481.
25. Compton, M.T., Walker, E.F., Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?. Schizophr. Bull. 35:2 (2009), 425–436.
26. Connor, S.E., Ng, V., McDonald, C., Schulze, K., Morgan, K., Dazzan, P., Murray, R.M., A study of hippocampal shape anomaly in schizophrenia and in families multiply affected by schizophrenia or bipolar disorder. Neuroradiology 46:7 (2004), 523–534.
27. Davis, K.L., Stewart, D.G., Friedman, J.I., Buchsbaum, M., Harvey, P.D., Hof, P.R., Buxbaum, J., Haroutunian, V., White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60:5 (2003), 443–456.
28. de Bartolomeis, A., Iasevoli, F., Tomasetti, C., Buonaguro, E.F., MicroRNAs in schizophrenia: implications for synaptic plasticity and dopamine-glutamate interaction at the postsynaptic density. New avenues for antipsychotic treatment under a theranostic perspective. Mol. Neurobiol. 52:3 (2015), 1771–1790.
29. Deep-Soboslay, A., Benes, F.M., Haroutunian, V., Ellis, J.K., Kleinman, J.E., Hyde, T.M., Psychiatric brain banking: three perspectives on current trends and future directions. Biol. Psychiatry 69:2 (2011), 104–112.
30. Dequeant, M.L., Pourquie, O., Segmental patterning of the vertebrate embryonic axis. Nat. Rev. Genet. 9:5 (2008), 370–382.
31. Dunham-Ems, S.M., Lee, Y.W., Stachowiak, E.K., Pudavar, H., Claus, P., Prasad, P.N., Stachowiak, M.K., Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control. Mol. Biol. Cell 20:9 (2009), 2401–2412.
32. Fang, X., Stachowiak, E.K., Dunham-Ems, S.M., Klejbor, I., Stachowiak, M.K., Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation. J. Biol. Chem. 280:31 (2005), 28451–28462.
33. Fatemi, S.H., Folsom, T.D., The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull. 35:3 (2009), 528–548.
34. Foussias, G., Mann, S., Zakzanis, K.K., van Reekum, R., Agid, O., Remington, G., Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits. Schizophr. Res. 132:1 (2011), 24–27.
35. Gonzalez, A.M., Berry, M., Maher, P.A., Logan, A., Baird, A., A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res. 701:1–2 (1995), 201–226.
36. Hamlyn, J., Duhig, M., McGrath, J., Scott, J., Modifiable risk factors for schizophrenia and autism–shared risk factors impacting on brain development. Neurobiol. Dis. 53 (2013), 3–9.
37. Han, X., Xiao, Z., Quarles, L.D., Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23. J. Biol. Chem., 290(33), 2015, 20101.
38. Hanzawa, S., Bae, J.K., Bae, Y.J., Chae, M.H., Tanaka, H., Nakane, H., Ohta, Y., Zhao, X., Iizuka, H., Nakane, Y., Psychological impact on caregivers traumatized by the violent behavior of a family member with schizophrenia. Asian J. Psychiatr. 6:1 (2013), 46–51.
39. Hashimoto-Torii, K., Torii, M., Fujimoto, M., Nakai, A., El Fatimy, R., Mezger, V., Ju, M.J., Ishii, S., Chao, S.H., Brennand, K.J., Gage, F.H., Rakic, P., Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. Neuron 82:3 (2014), 560–572.
40. Haw, R.A., Croft, D., Yung, C.K., Ndegwa, N., D'Eustachio, P., Hermjakob, H., Stein, L.D., The Reactome BioMart. Database, 2011, 2011, bar031.
41. Hill, M.J., Donocik, J.G., Nuamah, R.A., Mein, C.A., Sainz-Fuertes, R., Bray, N.J., Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells. Schizophr. Res. 153:1–3 (2014), 225–230.
42. Huttenhower, C., Haley, E.M., Hibbs, M.A., Dumeaux, V., Barrett, D.R., Coller, H.A., Troyanskaya, O.G., Exploring the human genome with functional maps. Genome Res. 19:6 (2009), 1093–1106.
43. International Schizophrenia, C., Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455:7210 (2008), 237–241.
44. Jungerius, B.J., Hoogendoorn, M.L., Bakker, S.C., Van't Slot, R., Bardoel, A.F., Ophoff, R.A., Wijmenga, C., Kahn, R.S., Sinke, R.J., An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol. Psychiatry 13:11 (2008), 1060–1068.
45. Kirov, G., Pocklington, A.J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., Grozeva, D., Fjodorova, M., Wollerton, R., Rees, E., Nikolov, I., van de Lagemaat, L.N., Bayes, A., Fernandez, E., Olason, P.I., Bottcher, Y., Komiyama, N.H., Collins, M.O., Choudhary, J., Stefansson, K., Stefansson, H., Grant, S.G., Purcell, S., Sklar, P., O'Donovan, M.C., Owen, M.J., De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17:2 (2012), 142–153.
46. Kneeland, R.E., Fatemi, S.H., Viral infection, inflammation and schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 42 (2013), 35–48.
47. Leadbeater, W.E., Gonzalez, A.M., Logaras, N., Berry, M., Turnbull, J.E., Logan, A., Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex. J. Neurochem. 96:4 (2006), 1189–1200.
48. Lee, Y.W., Terranova, C., Birkaya, B., Narla, S., Kehoe, D., Parikh, A., Dong, S., Ratzka, A., Brinkmann, H., Aletta, J.M., Tzanakakis, E.S., Stachowiak, E.K., Claus, P., Stachowiak, M.K., A novel nuclear FGF receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. J. Cell. Biochem. 113:9 (2012), 2920–2936.
49. Lee, Y.W., Stachowiak, E.K., Birkaya, B., Terranova, C., Capacchietti, M., Claus, P., Aletta, J.M., Stachowiak, M.K., NGF-induced cell differentiation and gene activation is mediated by integrative nuclear FGFR1 signaling (INFS). PLoS One, 8(7), 2013, e68931.
50. Lloyd, T., Dazzan, P., Dean, K., Park, S.B., Fearon, P., Doody, G.A., Tarrant, J., Morgan, K.D., Morgan, C., Hutchinson, G., Leff, J., Harrison, G., Murray, R.M., Jones, P.B., Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity. Psychol. Med. 38:1 (2008), 71–77.
51. Maher, P.A., Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:2 (1996), 529–536.
52. Stachowiak, M.K., Maher, P.A., Joy, A., Mordechai, E., Stachowiak, E.K., Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res. Mol. Brain Res. 38:1 (1996), 161–165.
53. Malhotra, D., McCarthy, S., Michaelson, J.J., Vacic, V., Burdick, K.E., Yoon, S., Cichon, S., Corvin, A., Gary, S., Gershon, E.S., Gill, M., Karayiorgou, M., Kelsoe, J.R., Krastoshevsky, O., Krause, V., Leibenluft, E., Levy, D.L., Makarov, V., Bhandari, A., Malhotra, A.K., McMahon, F.J., Nothen, M.M., Potash, J.B., Rietschel, M., Schulze, T.G., Sebat, J., High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72:6 (2011), 951–963.
54. Miller, B.H., Zeier, Z., Xi, L., Lanz, T.A., Deng, S., Strathmann, J., Willoughby, D., Kenny, P.J., Elsworth, J.D., Lawrence, M.S., Roth, R.H., Edbauer, D., Kleiman, R.J., Wahlestedt, C., MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc. Natl. Acad. Sci. U. S. A. 109:8 (2012), 3125–3130.
55. Moreau, M.P., Bruse, S.E., David-Rus, R., Buyske, S., Brzustowicz, L.M., Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 69:2 (2011), 188–193.
56. Narla, S.T., Klejbor, I., Birkaya, B., Lee, Y.W., Morys, J., Stachowiak, E.K., Prokop, D., Bencherif, M., Stachowiak, M.K., Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by alpha7 nicotinic receptor agonist. Stem Cells Transl. Med. 2:10 (2013), 776–788.
57. Need, A.C., Attix, D.K., McEvoy, J.M., Cirulli, E.T., Linney, K.L., Hunt, P., Ge, D., Heinzen, E.L., Maia, J.M., Shianna, K.V., Weale, M.E., Cherkas, L.F., Clement, G., Spector, T.D., Gibson, G., Goldstein, D.B., A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Hum. Mol. Genet. 18:23 (2009), 4650–4661.
58. Palaniyappan, L., Al-Radaideh, A., Mougin, O., Gowland, P., Liddle, P.F., Combined white matter imaging suggests myelination defects in visual processing regions in schizophrenia. Neuropsychopharmacology 38:9 (2013), 1808–1815.
59. Partanen, J., Schwartz, L., Rossant, J., Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev. 12:15 (1998), 2332–2344.
60. Paulsen, B.D., Maciel, R.D., Galina, A., da Silveira, M.S., Souza, C.D., Drummond, H., Pozzato, E.N., Junior, H.S., Chicaybam, L., Massuda, R., Setti-Perdigao, P., Bonamino, M., Belmonte-de-Abreu, P.S., Castro, N.G., Brentani, H., Rehen, S.K., Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant., 2011.
61. Peng, H., Moffett, J., Myers, J., Fang, X., Stachowiak, E.K., Maher, P., Kratz, E., Hines, J., Fluharty, S.J., Mizukoshi, E., Bloom, D.C., Stachowiak, M.K., Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol. Biol. Cell 12:2 (2001), 449–462.
62. Peng, H., Myers, J., Fang, X., Stachowiak, E.K., Maher, P.A., Martins, G.G., Popescu, G., Berezney, R., Stachowiak, M.K., Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J. Neurochem. 81:3 (2002), 506–524.
63. Perkins, D.O., Jeffries, C.D., Jarskog, L.F., Thomson, J.M., Woods, K., Newman, M.A., Parker, J.S., Jin, J., Hammond, S.M., MicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol., 8(2), 2007, R27.
64. Pollerberg, G.E., Thelen, K., Theiss, M.O., Hochlehnert, B.C., The role of cell adhesion molecules for navigating axons: density matters. Mech. Dev. 130:6–8 (2013), 359–372.
65. Rehn, A.E., Rees, S.M., Investigating the neurodevelopmental hypothesis of schizophrenia. Clin. Exp. Pharmacol. Physiol. 32:9 (2005), 687–696.
66. Reilly, J.F., Maher, P.A., Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J. Cell Biol. 152:6 (2001), 1307–1312.
67. Robicsek, O., Karry, R., Petit, I., Salman-Kesner, N., Muller, F.J., Klein, E., Aberdam, D., Ben-Shachar, D., Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol. Psychiatry, 2013.
68. Roussos, P., Guennewig, B., Kaczorowski, D.C., Barry, G., Brennand, K.J., Activity-dependent changes in gene expression in schizophrenia human-induced pluripotent stem cell neurons. JAMA Psychiat. 73:11 (2016), 1180–1188.
69. Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Kissling, W., Davis, J.M., Leucht, S., Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr. Bull. 38:1 (2012), 167–177.
70. Saha, S., Chant, D., Welham, J., McGrath, J., A systematic review of the prevalence of schizophrenia. PLoS Med., 2(5), 2005, e141.
71. Santarelli, D.M., Beveridge, N.J., Tooney, P.A., Cairns, M.J., Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 69:2 (2011), 180–187.
72. Schiller, D., Zuckerman, L., Weiner, I., Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol. J. Psychiatr. Res. 40:2 (2006), 167–177.
73. Schmiedel, J.M., Klemm, S.L., Zheng, Y., Sahay, A., Bluthgen, N., Marks, D.S., van Oudenaarden, A., Gene expression. MicroRNA control of protein expression noise. Science 348:6230 (2015), 128–132.
74. Shi, W., Du, J., Qi, Y., Liang, G., Wang, T., Li, S., Xie, S., Zeshan, B., Xiao, Z., Aberrant expression of serum miRNAs in schizophrenia. J. Psychiatr. Res. 46:2 (2012), 198–204.
75. Srikanth, P., Han, K., Callahan, D.G., Makovkina, E., Muratore, C.R., Lalli, M.A., Zhou, H., Boyd, J.D., Kosik, K.S., Selkoe, D.J., Young-Pearse, T.L., Genomic DISC1 disruption in hiPSCs alters Wnt signaling and neural cell fate. Cell Rep. 12:9 (2015), 1414–1429.
76. Stachowiak, M.K., Stachowiak, E.K., Evidence-based theory for integrated genome regulation of ontogeny-an unprecedented role of nuclear FGFR1 signaling. J. Cell. Physiol. 231:6 (2016), 1199–1218.
77. Stachowiak, M.K., Maher, P.A., Joy, A., Mordechai, E., Stachowiak, E.K., Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol. Biol. Cell 7:8 (1996), 1299–1317.
78. Stachowiak, E.K., Fang, X., Myers, J., Dunham, S., Stachowiak, M.K., cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J. Neurochem. 84:6 (2003), 1296–1312.
79. Stachowiak, M.K., Maher, P.A., Stachowiak, E.K., Integrative nuclear signaling in cell development–a role for FGF receptor-1. DNA Cell Biol. 26:12 (2007), 811–826.
80. Stachowiak, M.K., Stachowiak, E.K., Aletta, J.M., Tzanakakis, E.S., A Common Integrative Nuclear Signaling Module for Stem Cell Development. Stachowiak, M.K., E.S.T, (eds.) Stem Cells from Mechanisms to Technologies, 2011, World Scientific, 87–132.
81. Stachowiak, M.K., Kucinski, A., Curl, R., Syposs, C., Yang, Y., Narla, S., Terranova, C., Prokop, D., Klejbor, I., Bencherif, M., Birkaya, B., Corso, T., Parikh, A., Tzanakakis, E.S., Wersinger, S., Stachowiak, E.K., Schizophrenia: a neurodevelopmental disorder–integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophr. Res. 143:2–3 (2013), 367–376.
82. Stachowiak, M.K., Birkaya, B., Aletta, J.M., Narla, S.T., Benson, C.A., Decker, B., Stachowiak, E.K., Nuclear FGF receptor-1 and CREB binding protein: an integrative signaling module. J. Cell. Physiol. 230:5 (2015), 989–1002.
83. Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O.P., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J.E., Hansen, T., Jakobsen, K.D., Muglia, P., Francks, C., Matthews, P.M., Gylfason, A., Halldorsson, B.V., Gudbjartsson, D., Thorgeirsson, T.E., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., Bjornsson, A., Mattiasdottir, S., Blondal, T., Haraldsson, M., Magnusdottir, B.B., Giegling, I., Moller, H.J., Hartmann, A., Shianna, K.V., Ge, D., Need, A.C., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Paunio, T., Toulopoulou, T., Bramon, E., Di Forti, M., Murray, R., Ruggeri, M., Vassos, E., Tosato, S., Walshe, M., Li, T., Vasilescu, C., Muhleisen, T.W., Wang, A.G., Ullum, H., Djurovic, S., Melle, I., Olesen, J., Kiemeney, L.A., Franke, B., Group, Sabatti, C., Freimer, N.B., Gulcher, J.R., Thorsteinsdottir, U., Kong, A., Andreassen, O.A., Ophoff, R.A., Georgi, A., Rietschel, M., Werge, T., Petursson, H., Goldstein, D.B., Nothen, M.M., Peltonen, L., Collier, D.A., St Clair, D., Stefansson, K., Large recurrent microdeletions associated with schizophrenia. Nature 455:7210 (2008), 232–236.
84. Stuhlmiller, T.J., Garcia-Castro, M.I., FGF/MAPK signaling is required in the gastrula epiblast for avian neural crest induction. Development 139:2 (2012), 289–300.
85. Sullivan, P.F., Kendler, K.S., Neale, M.C., Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60:12 (2003), 1187–1192.
86. Terranova, C., Narla, S.T., Lee, Y.W., Bard, J., Parikh, A., Stachowiak, E.K., Tzanakakis, E.S., Buck, M.J., Birkaya, B., Stachowiak, M.K., Global developmental gene programing involves a nuclear form of fibroblast growth factor receptor-1 (FGFR1). PLoS One, 10(4), 2015, e0123380.
87. Topol, A., English, J.A., Flaherty, E., Rajarajan, P., Hartley, B.J., Gupta, S., Desland, F., Zhu, S., Goff, T., Friedman, L., Rapoport, J., Felsenfeld, D., Cagney, G., Mackay-Sim, A., Savas, J.N., Aronow, B., Fang, G., Zhang, B., Cotter, D., Brennand, K.J., Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients. Transl. Psychiatry, 5, 2015, e662.
88. Topol, A., Zhu, S., Tran, N., Simone, A., Fang, G., Brennand, K.J., Altered WNT signaling in human induced pluripotent stem cell neural progenitor cells derived from four schizophrenia patients. Biol. Psychiatry 78:6 (2015), e29–e34.
89. Topol, A., Zhu, S., Hartley, B.J., English, J., Hauberg, M.E., Tran, N., Rittenhouse, C.A., Simone, A., Ruderfer, D.M., Johnson, J., Readhead, B., Hadas, Y., Gochman, P.A., Wang, Y.C., Shah, H., Cagney, G., Rapoport, J., Gage, F.H., Dudley, J.T., Sklar, P., Mattheisen, M., Cotter, D., Fang, G., Brennand, K.J., Dysregulation of miRNA-9 in a subset of schizophrenia patient-derived neural progenitor cells. Cell Rep. 15:5 (2016), 1024–1036.
90. Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L., Pachter, L., Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7:3 (2012), 562–578.
91. Walsh, T., McClellan, J.M., McCarthy, S.E., Addington, A.M., Pierce, S.B., Cooper, G.M., Nord, A.S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S.M., Rippey, C.F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R.L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E.E., Meltzer, P.S., Nelson, S.F., Singleton, A.B., Lee, M.K., Rapoport, J.L., King, M.C., Sebat, J., Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:5875 (2008), 539–543.
92. Wang, H., Zou, J., Zhao, B., Johannsen, E., Ashworth, T., Wong, H., Pear, W.S., Schug, J., Blacklow, S.C., Arnett, K.L., Bernstein, B.E., Kieff, E., Aster, J.C., Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc. Natl. Acad. Sci. U. S. A. 108:36 (2011), 14908–14913.
93. Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., Parkinson, H., The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42 (2014), D1001–D1006 (Database issue).
94. Wen, Z., Nguyen, H.N., Guo, Z., Lalli, M.A., Wang, X., Su, Y., Kim, N.S., Yoon, K.J., Shin, J., Zhang, C., Makri, G., Nauen, D., Yu, H., Guzman, E., Chiang, C.H., Yoritomo, N., Kaibuchi, K., Zou, J., Christian, K.M., Cheng, L., Ross, C.A., Margolis, R.L., Chen, G., Kosik, K.S., Song, H., Ming, G.L., Synaptic dysregulation in a human iPS cell model of mental disorders. Nature, 2014.
95. Xu, B., Roos, J.L., Levy, S., van Rensburg, E.J., Gogos, J.A., Karayiorgou, M., Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40:7 (2008), 880–885.
96. Xu, J., Hartley, B.J., Kurup, P., Phillips, A., Topol, A., Xu, M., Ononenyi, C., Foscue, E., Ho, S.M., Baguley, T.D., Carty, N., Barros, C.S., Muller, U., Gupta, S., Gochman, P., Rapoport, J., Ellman, J.A., Pittenger, C., Aronow, B., Nairn, A.C., Nestor, M.W., Lombroso, P.J., Brennand, K.J., Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models. Mol. Psychiatry, 2016.
97. Yoon, K.J., Nguyen, H.N., Ursini, G., Zhang, F., Kim, N.S., Wen, Z., Makri, G., Nauen, D., Shin, J.H., Park, Y., Chung, R., Pekle, E., Zhang, C., Towe, M., Hussaini, S.M., Lee, Y., Rujescu, D., St Clair, D., Kleinman, J.E., Hyde, T.M., Krauss, G., Christian, K.M., Rapoport, J.L., Weinberger, D.R., Song, H., Ming, G.L., Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. Cell Stem Cell 15:1 (2014), 79–91.
98. Younger, S.T., Corey, D.R., Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res. 39:13 (2011), 5682–5691.
99. Yu, D.X., Di Giorgio, F.P., Yao, J., Marchetto, M.C., Brennand, K., Wright, R., Mei, A., McHenry, L., Lisuk, D., Grasmick, J.M., Silberman, P., Silberman, G., Jappelli, R., Gage, F.H., Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Rep. 2:3 (2014), 295–310.
100. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., Liu, X.S., Model-based analysis of ChIP-seq (MACS). Genome Biol., 9(9), 2008, R137.